These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29587898)

  • 1. [Preface].
    Liu L; Chen K; Gao S
    Zhongguo Fei Ai Za Zhi; 2018 Apr; 21(4):251. PubMed ID: 29587898
    [No Abstract]   [Full Text] [Related]  

  • 2. [University center on rare diseases, as a successful example of the integration of the clinical sector into the system of medical education].
    Vadachkoriia ZO; Abesadze GG; Pagava KI; Korinteli IA
    Georgian Med News; 2011 Apr; (193):20-2. PubMed ID: 21617268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaboration is key to treating uncommon cancers: scientists and patients champion research in these rare diseases.
    Printz C
    Cancer; 2010 Jun; 116(12):2847-9. PubMed ID: 20564387
    [No Abstract]   [Full Text] [Related]  

  • 4. The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRT.
    Ferrari A; Schneider DT; Bisogno G;
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):1-3. PubMed ID: 23259419
    [No Abstract]   [Full Text] [Related]  

  • 5. [Centralized treatment of rare types of cancer].
    Schem BC
    Tidsskr Nor Laegeforen; 2002 Sep; 122(21):2088. PubMed ID: 12555641
    [No Abstract]   [Full Text] [Related]  

  • 6. Do we need randomised trials for rare cancers?
    Prasad V; Oseran A
    Eur J Cancer; 2015 Jul; 51(11):1355-7. PubMed ID: 25963018
    [No Abstract]   [Full Text] [Related]  

  • 7. International rare cancers initiative.
    Keat N; Law K; Seymour M; Welch J; Trimble T; Lascombe D; Negrouk A
    Lancet Oncol; 2013 Feb; 14(2):109-10. PubMed ID: 23369681
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rare tumors: the need for special centers].
    Massard C
    Bull Cancer; 2014 Feb; 101(2):115. PubMed ID: 25813683
    [No Abstract]   [Full Text] [Related]  

  • 9. "People with rare cancers get a raw deal in research and care".
    Newlands J
    Nurs Times; 2012 Feb 7-13; 108(6):11. PubMed ID: 22720483
    [No Abstract]   [Full Text] [Related]  

  • 10. What a strange thing it is to live.
    García Jordá E
    Clin Transl Oncol; 2009 Mar; 11(3):123-5. PubMed ID: 19293048
    [No Abstract]   [Full Text] [Related]  

  • 11. Rethinking the nonprofit foundation: an emerging niche in the rare disease ecosystem.
    Bakker AC; La Rosa S
    EMBO Mol Med; 2017 Sep; 9(9):1179-1182. PubMed ID: 28743783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy for randomised clinical trials in rare cancers.
    Tan SB; Dear KB; Bruzzi P; Machin D
    BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should clinical trials be approached differently for rare cancers?
    Olver I
    Future Oncol; 2016 May; 12(10):1207-9. PubMed ID: 26939845
    [No Abstract]   [Full Text] [Related]  

  • 14. Specialized teams or specialist networks for rare cancers?
    Sandrucci S; Gatta G; Trama A; Dei Tos AP; Casali PG
    Eur J Surg Oncol; 2015 Sep; 41(9):1115-7. PubMed ID: 25936223
    [No Abstract]   [Full Text] [Related]  

  • 15. [Care networks in oncology, an evidence for all?].
    Ray-Coquard I; Ducimetière F; Farsi F
    Bull Cancer; 2013; 100(7-8):650-4. PubMed ID: 24063023
    [No Abstract]   [Full Text] [Related]  

  • 16. A quarter of patients with rarer cancers see GPs several times before referral.
    Mayor S
    BMJ; 2016 Feb; 352():i1198. PubMed ID: 26929277
    [No Abstract]   [Full Text] [Related]  

  • 17. Preface.
    Singh AD
    Int Ophthalmol Clin; 2015; 55(1):vii. PubMed ID: 25436500
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing treatment strategies for rare cancers.
    Atkinson JM; Gilbertson RJ
    Oncotarget; 2011 Sep; 2(9):657. PubMed ID: 21969078
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: Special issue on rare cancers.
    Sandler A; Reilly K; Widemann B
    Curr Probl Cancer; 2021 Aug; 45(4):100774. PubMed ID: 34304884
    [No Abstract]   [Full Text] [Related]  

  • 20. To make progress in rare cancers, patients must lead the way.
    Dockser Marcus A
    J Clin Oncol; 2009 Jun; 27(16):2575-7. PubMed ID: 19414666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.